Alleviation of Alopecia in Breast Cancer Patient Using Synbiotics Formula
Recruiting
N/A
Interventional Study
Breast Cancer
Hair Loss
At a Glance
- Age
- 18 – 60
- Sex
- Female
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 40 (estimated)
- Sponsor
- GenieBiome Limited · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to explore the efficacy and safety of a synbiotic formula (BLHK03) in alleviating chemotherapy-induced alopecia (CIA) in breast cancer patients and the compositional and functional changes in the gut microbiome of breast cancer patients undergoing chemotherapy and treatment with BLHK03.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Females aged between 18 and 60 years who are newly diagnosed with stage I, II or III breast cancer
* Planned chemotherapy including an anthracycline or taxane to be completed within 6 months
* Mentally capable to participate in the study and provide informed consent
Exclusion…
Contacts